Skin biopsy test detects abnormalities of key biomarker in neurodegenerative disorders
Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders
Read More
Tag: alpha-synuclein
Key Parkinson’s protein could offer new potential targets for treatment
The findings could lead to new treatments to target the mTOR and ease PD symptoms
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
